Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens.
about
Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and SafetyThe response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab.A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients.Active idiotypic vaccination versus control immunotherapy for follicular lymphomaRobust memory responses against influenza vaccination in pemphigus patients previously treated with rituximabImpaired B cell immunity in acute myeloid leukemia patients after chemotherapy.2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.Immunreconstitution and infectious complications after rituximab treatment in children and adolescents: what do we know and what can we learn from adults?Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis.Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system.Rituximab-treated patients have a poor response to influenza vaccinationHuman Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients.HIV-dependent depletion of influenza-specific memory B cells impacts B cell responsiveness to seasonal influenza immunisation.Immunogenicity of a monovalent influenza A(H1N1)pdm09 vaccine in patients with hematological malignancies.Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 yearsInfectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.Treatments for hematologic malignancies in contrast to those for solid cancers are associated with reduced red cell alloimmunization.Vaccination against infection in patients with multiple sclerosis.Rituximab in the treatment of non-Hodgkin's lymphoma--a critical evaluation of randomized controlled trials.Vaccines and biologics.A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin's lymphomas.Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients.Prophylactic immunoglobulin therapy in secondary immune deficiency - an expert opinion.Rituximab for the treatment of follicular lymphoma.BI 1002494, a Novel Potent and Selective Oral Spleen Tyrosine Kinase Inhibitor, Displays Differential Potency in Human Basophils and B Cells.Risk factors predisposing to the development of hypogammaglobulinemia and infections post-Rituximab.Characterization of the B cell response to Leishmania infection after anti-CD20 B cell depletion.B cell depletion curtails CD4+ T cell memory and reduces protection against disseminating virus infection.Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM).Influenza vaccination in oncology patients.Virus-specific antibody secreting cell, memory B-cell, and sero-antibody responses in the human influenza challenge model.Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimensAnti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).
P2860
Q28079486-AF75E789-89E4-4569-987A-80BA66042A32Q30362892-EE2FA635-C5AD-4C45-9398-312007B91D7FQ30413413-2086A914-09C8-4D0E-8915-9EDBCE64A1BEQ33691505-E51B81C2-A2DB-4FAD-B596-7CAA6BA1D945Q33798060-41451F44-2CFE-4FA7-8EA4-D319892129F0Q33892358-EA04E57D-A1B4-475C-8216-3B4D4F578B2BQ34390072-D2FADCBF-E1EC-4775-AB99-6EBA188951FEQ35237511-ED46300A-BDB4-4BC3-A47E-2474E95660AEQ35541507-73AE9383-343F-486A-9471-66E9DFE94DEDQ35952784-FC262D96-D16A-4631-B823-41DD30363FDDQ36589247-047BB3C7-C99F-4C0C-8719-FC085E76947EQ36822761-90794A61-3633-451C-B962-B2F0D3D929DAQ36933809-523D27F9-7328-4EFB-9AD0-7CBD0FBFF526Q36978418-D3071DD1-69A2-4147-82F7-F672BF0B96E4Q37115262-60538278-4CCC-49D0-8D84-952ECDE9160BQ37150434-67CF8A73-99CB-4F7F-8116-6130983502C7Q37555796-71D14F1E-08E7-4750-816E-C8A2A7E1B427Q37978121-39EF142E-971B-46FC-A5F0-2F6894215557Q38096425-F43D092C-F42E-4FD1-894C-B77D5255E8C1Q38213192-3A82D74B-E940-4A5E-84D9-335240EB9CC8Q38465823-56A8B5F4-4726-4E0F-BE27-2BD5BB07EBCFQ38842494-B1B1632A-5C7D-49B1-9122-8A3C15DFFB75Q38896505-93812B4E-14B0-4DE8-8F57-3B89943164E1Q39360775-EA41A612-92C3-411A-A164-14A74754AD16Q39860557-86A75D18-1931-4E51-A6C1-878CC72AD2FAQ40097140-BBF735C0-3C03-4CFE-9386-5178CFDFBE84Q41059758-8E2F82C9-528A-4110-AE64-6BA92E221CDFQ41957699-A0A94203-FEF4-4747-A609-BD96DD6A87D6Q42224597-5D08F5CB-5758-473F-9364-852797FDB5F3Q42239906-35608CEF-8903-4DE1-9C3A-D5AE9BBFCC7CQ42243814-37298512-20AE-4092-B47B-8DB873278FDCQ42322729-A9CD767F-B19C-41AA-BAFD-1D5A9BCF4F18Q55364518-844FE4DE-7B50-4413-8B37-C7D754C1931C
P2860
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Impaired response to influenza ...... rituximab-containing regimens.
@ast
Impaired response to influenza ...... rituximab-containing regimens.
@en
type
label
Impaired response to influenza ...... rituximab-containing regimens.
@ast
Impaired response to influenza ...... rituximab-containing regimens.
@en
prefLabel
Impaired response to influenza ...... rituximab-containing regimens.
@ast
Impaired response to influenza ...... rituximab-containing regimens.
@en
P2093
P2860
P50
P356
P1476
Impaired response to influenza ...... rituximab-containing regimens
@en
P2093
Andrea Bruzzone
Andrea De Maria
Carlotta Massucco
Elisa Zanardi
Enrico Balleari
Filippo Ansaldi
Francesco Boccardo
Francesco M Marincola
Giancarlo Icardi
Graziano Caltabiano
P2860
P304
P356
10.4049/JIMMUNOL.1004095
P407
P577
2011-04-15T00:00:00Z